Antonio Urbina, MD

Although a cure is likely still a ways off, continuing to pursue long-acting injectable treatments and PrEP is key to reducing cases of HIV.

Lenacapavir and cabotegravir are among the most important advancements in HIV prevention and treatment within the past 10 years.